BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20408122)

  • 1. Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue® low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI.
    Cantisani V; Ricci P; Erturk M; Pagliara E; Drudi F; Calliada F; Mortele K; D'Ambrosio U; Marigliano C; Catalano C; Marin D; Di Seri M; Longo F; Passariello R
    Ultraschall Med; 2010 Oct; 31(5):500-5. PubMed ID: 20408122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Sano M; Kato S; Kitamura T; Fatima Z; Fukushima K; Iino H; Mori Y; Fujii H; Araki T
    J Magn Reson Imaging; 2011 Aug; 34(2):326-35. PubMed ID: 21780227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies.
    Frieser M; Kiesel J; Lindner A; Bernatik T; Haensler JM; Janka R; Hahn EG; Strobel D
    Ultraschall Med; 2011 Apr; 32(2):148-53. PubMed ID: 21225567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound vs multidetector-computed tomography for detecting liver metastases in colorectal cancer: a prospective, blinded, patient-by-patient analysis.
    Rafaelsen SR; Jakobsen A
    Colorectal Dis; 2011 Apr; 13(4):420-5. PubMed ID: 20412096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI findings of hepatocellular carcinoma.
    Wiwanitkit V
    Magn Reson Imaging; 2011 Feb; 29(2):303. PubMed ID: 21129874
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of malignant liver tumors: biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound.
    Clevert DA; Jung EM; Stock KF; Weckbach S; Feuerbach S; Reiser M; Jung F
    Z Gastroenterol; 2009 Dec; 47(12):1195-202. PubMed ID: 19960397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI findings of rapidly progressive hepatocellular carcinoma.
    Kierans AS; Leonardou P; Hayashi P; Brubaker LM; Elazzazi M; Shaikh F; Semelka RC
    Magn Reson Imaging; 2010 Jul; 28(6):790-6. PubMed ID: 20427139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dark lumen MR colonography: can high spatial resolution VIBE imaging improve the detection of colorectal masses?
    Ajaj W; Rühm SG; Papanikolaou N; Lauenstein TC; Gerken G; Goyen M
    Rofo; 2006 Nov; 178(11):1073-8. PubMed ID: 17128377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of different MRI sequences with and without application of Gd-BOPTA as follow-up after LITT].
    Pech M; Spors B; Wieners G; Warschewske G; Beck A; Cho C; Fischbach F; Ricke J
    Rofo; 2004 Apr; 176(4):550-5. PubMed ID: 15088180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
    Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
    Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of single injection liver arterial phase gadolinium enhanced MRI using bolus track real-time imaging.
    Sharma P; Kalb B; Kitajima HD; Salman KN; Burrow B; Ray GL; Martin DR
    J Magn Reson Imaging; 2011 Jan; 33(1):110-8. PubMed ID: 21182128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic transit time analysis using contrast enhanced MRI with Gd-BOPTA: A prospective study comparing patients with liver metastases from colorectal cancer and healthy volunteers.
    Hohmann J; Newerla C; Müller A; Reinicke C; Skrok J; Frericks BB; Albrecht T
    J Magn Reson Imaging; 2012 Dec; 36(6):1389-94. PubMed ID: 22893441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple cavernous hemangioma progressing in size in a cirrhotic liver].
    Henninger B; Bale R; Schocke M
    Rofo; 2010 Apr; 182(4):357-9. PubMed ID: 19953432
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of contrast agent-enhanced versus non-contrast agent-enhanced real-time three-dimensional echocardiography for analysis of left ventricular systolic function.
    Krenning BJ; Kirschbaum SW; Soliman OI; Nemes A; van Geuns RJ; Vletter WB; Veltman CE; Ten Cate FJ; Roelandt JR; Geleijnse ML
    Am J Cardiol; 2007 Nov; 100(9):1485-9. PubMed ID: 17950813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound.
    Goetti R; Reiner CS; Knuth A; Klotz E; Stenner F; Samaras P; Alkadhi H
    Invest Radiol; 2012 Jan; 47(1):18-24. PubMed ID: 21788906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization by biopsy or CEUS of liver lesions guided by image fusion between ultrasonography and CT, PET/CT or MRI.
    Ewertsen C; Henriksen BM; Torp-Pedersen S; Bachmann Nielsen M
    Ultraschall Med; 2011 Apr; 32(2):191-7. PubMed ID: 21225564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hepatic hypovascular metastases: 3D gradient echo MRI using a hepatobiliary contrast agent.
    Choi JY; Choi JS; Kim MJ; Lim JS; Park MS; Kim JH; Chung YE
    J Magn Reson Imaging; 2010 Mar; 31(3):571-8. PubMed ID: 20187199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.